Brian Goff is Chief Executive Officer of Agios Pharmaceuticals Inc.
Person profile
Roles
Agios Pharmaceuticals
Chief Executive Officer
Address
New Haven, Connecticut
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
AGIOS PHARMACEUTICALS, INC.
3 Mar 23
3
AGIOS PHARMACEUTICALS, INC.
9 Aug 22
3/A
AGIOS PHARMACEUTICALS, INC.
9 Aug 22
4
AGIOS PHARMACEUTICALS, INC.
9 Aug 22
4
ALEXION PHARMACEUTICALS, INC.
23 Jul 21
4
ALEXION PHARMACEUTICALS, INC.
16 Jul 21
4
ALEXION PHARMACEUTICALS, INC.
9 Jun 21
4
ALEXION PHARMACEUTICALS, INC.
2 Mar 21
4
ALEXION PHARMACEUTICALS, INC.
18 Dec 20
4
ALEXION PHARMACEUTICALS, INC.
9 Jun 20
Recent insider trades
| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 Mar 23 | AGIO Agios Pharmaceuticals | Stock options Common stock | Grant | Acquire A | No | No | 25.01 | 94,500 | 2.36 mm | 94,500 |
| 1 Mar 23 | AGIO Agios Pharmaceuticals | RSU Common stock | Grant | Acquire A | No | No | 0 | 25,500 | 0.00 | 25,500 |
| 8 Aug 22 | AGIO Agios Pharmaceuticals | RSU Common stock | Grant | Acquire A | No | No | 0 | 68,073 | 0.00 | 68,073 |
| 8 Aug 22 | AGIO Agios Pharmaceuticals | Stock option Common stock | Grant | Acquire A | No | No | 29.38 | 561,083 | 16.48 mm | 561,083 |